Johan D. Boot
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
Journal: The Journal of allergy and clinical immunology
Published: May 16, 2018
Sputum RNA signature in allergic asthmatics following allergen bronchoprovocation test.
Journal: European clinical respiratory journal
Published: February 15, 2016
House dust mite-specific IgA2 is associated with protection against eczema in allergic patients.
Journal: Allergy
Published: November 12, 2015
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen.
Journal: European clinical respiratory journal
Published: April 22, 2015
Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
Journal: Pulmonary pharmacology & therapeutics
Published: February 01, 2015
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.
Journal: Clinical and translational allergy
Published: February 18, 2014
Observational study of the safety of a cluster schedule for subcutaneous immunotherapy in a pediatric population.
Journal: Journal of investigational allergology & clinical immunology
Published: May 10, 2013
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients.
Journal: Clinical and translational allergy
Published: December 18, 2012
Last Updated: 09/26/2026